SCHEMBL19686572

SCHEMBL19686572

O=C(N[C@@H](CCC1CCC1)B(O)O)[C@H](Cc1ccccc1)NS(=O)(=O)c1cc(F)ccc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 17/20 0.49
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PSMB1 P20618 3/20 0.41
▸ PSMB2 P49721 3/20 0.41
▸ PSMB11 A5LHX3 1/20 0.41
▸ PSMA7 O14818 1/20 0.41
▸ PSMA1 P25786 1/20 0.41
▸ PSMA2 P25787 1/20 0.41
▸ PSMA3 P25788 1/20 0.41
▸ PSMA4 P25789 1/20 0.41
▸ PSMB8 P28062 1/20 0.41
▸ PSMB9 P28065 1/20 0.41
▸ PSMA5 P28066 1/20 0.41
▸ PSMB4 P28070 1/20 0.41
▸ PSMB6 P28072 1/20 0.41
▸ LONP1 P36776 1/20 0.41
▸ PSMB10 P40306 1/20 0.41
▸ PSMB3 P49720 1/20 0.41
▸ PSMA6 P60900 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3149025 0.91 PSMB5 (0.51) PSMB5CYP3A4CYP2C19PSMB1PSMB2
SCHEMBL19387845 0.85 PSMB5 (0.70) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL3149386 0.76 PSMB5 (0.72) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL19387801 0.75 PSMB5 (0.45) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL19687309 0.74 ALDH1A1 (0.42) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL19387844 0.73 F2 (0.44) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL3148972 0.72 NPY5R (0.56) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL13380914 0.70 PSMB5 (0.49) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL3139093 0.69 PSMB5 (0.56) PSMB5PSMB1PSMB2PSMB11PSMA7
SCHEMBL3143980 0.69 PSMB5 (0.46) PSMB5PSMB1PSMB2PSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035811-B2 Derivatives of 1-amino-2-cyclobutylethylboronic acid MILLENNIUM PHARMACEUTICALS, INC. (US) 2018-07-31 — — US disclosed
US-20170349611-A1 DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035811-B2 Derivatives of 1-amino-2-cyclobutylethylboronic acid PSMB6, PSMB5, PSMB1 PSMB5 2/4885CYP3A4 4412/4885CYP2C19 3951/4885
US-20170349611-A1 DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBORONIC ACID PSMB6, PSMB5, PSMB1 PSMB5 2/4885CYP3A4 4412/4885CYP2C19 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback